<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Meningococcal disease</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Meningococcal disease.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/meningococcal-disease.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in USA and Puerto Rico: Results from a Phase III, randomized, active-controlled study.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-21645515-2026-2716508-f8e301e4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-21645515-2026-2716508-f8e301e4/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>Establishing the safety of this vaccine when combined with routine pediatric immunizations aids regulatory approval and clinical administration guidelines. The data contributes to understanding potential interactions within standard infant vaccination protocols.</description>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Pertussis</category>
    <category>Meningococcal disease</category>
    <category>Varicella</category>
    <category>Hepatitis B</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Vaccine-preventable disease outbreaks in schools, part 2: pertussis, meningococcal disease, diphtheria, poliomyelitis, hepatitis A, and rotavirus infection</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128750-3c0b0e8a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128750-3c0b0e8a/</guid>
    <pubDate>Mon, 01 Jun 2026 00:00:00 GMT</pubDate>
    <description>The review frames schools as environments where vaccine-preventable diseases can spread and where outbreaks can disrupt normal activities. It also states that falling vaccination coverage may increase outbreak risk and that vaccination services, surveillance, and diagnostic capacity should be strengthened.</description>
    <category>Poliomyelitis</category>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Meningococcal disease</category>
    <category>Rotavirus infection</category>
    <category>Hepatitis A</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-3-2500431-37258000/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-3-2500431-37258000/</guid>
    <pubDate>Thu, 22 Jan 2026 00:00:00 GMT</pubDate>
    <description>The investigation demonstrates the value of pharyngeal swabbing for outbreak strain identification and provides initial safety evidence for off-label use of MenB-fHbp vaccine in young children who had previously received 4CMenB vaccination.</description>
    <category>Meningococcal disease</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare porA genosubtype (19-54, 15), Spain, March to April 2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2025-30-44-2500222-f030b3b1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2025-30-44-2500222-f030b3b1/</guid>
    <pubDate>Thu, 06 Nov 2025 00:00:00 GMT</pubDate>
    <description>The report illustrates how surveillance-triggered microbiological and immunological work-up can guide targeted chemoprophylaxis and 4CMenB vaccination among a large contact network, and underscores the need to monitor emergence of the 19-54 genosubtype.</description>
    <category>Meningococcal disease</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Current global trends in meningococcal disease control, risk groups and vaccination: Consensus of the Global Meningococcal Initiative</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2025-106635-94449766/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2025-106635-94449766/</guid>
    <pubDate>Sat, 01 Nov 2025 00:00:00 GMT</pubDate>
    <description>These observations underscore evolving transmission patterns and atypical disease manifestations that may necessitate adjustments to routine immunization schedules and travel-related health advisories.</description>
    <category>COVID-19</category>
    <category>Meningococcal disease</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Travel medicine</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900–2015</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2018-01-065-bc387b6f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2018-01-065-bc387b6f/</guid>
    <pubDate>Thu, 01 Mar 2018 00:00:00 GMT</pubDate>
    <description>The authors frame universal vaccination programs as a highly effective prevention tool and emphasize that health authorities should reinforce public confidence in vaccines by communicating the scientific evidence of their benefits.</description>
    <category>Measles</category>
    <category>Diphtheria</category>
    <category>Rubella</category>
    <category>Poliomyelitis</category>
    <category>Mumps</category>
    <category>Hepatitis B</category>
    <category>Pertussis</category>
    <category>Meningococcal disease</category>
    <category>Tetanus</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Global epidemiology of meningococcal disease</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2009-04-063-92a6a7dd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2009-04-063-92a6a7dd/</guid>
    <pubDate>Mon, 01 Jun 2009 00:00:00 GMT</pubDate>
    <description>Surveillance data are essential for vaccine formulation, vaccination policy decisions, and monitoring vaccine impact. The dynamic and regionally variable epidemiology of meningococcal disease necessitates ongoing surveillance to guide public health interventions.</description>
    <category>Meningococcal disease</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-esm-11-07-00635-en-e927caca/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-esm-11-07-00635-en-e927caca/</guid>
    <pubDate>Sat, 01 Jul 2006 00:00:00 GMT</pubDate>
    <description>Health authorities implemented enhanced surveillance and practitioner education in 2003. Following advisory board review in 2004, the Ministry of Health decided in 2006 to offer vaccination using a Norwegian outer membrane vesicle vaccine to persons aged 1 to 19 years in Seine-Maritime.</description>
    <category>Meningococcal disease</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
